Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00719901 · BASELINE

Baseline characteristics

Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma · Source last updated 2015-01-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      10
    units
    Participants
groups
  1. description
    Patients receive obatoclax mesylate IV over 3 hours and bortezomib (1.3 mg/m\^2) IV on days 1, 4, 8, and 11. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
    id
    BG000
    title
    Treatment (Enzyme Inhibitor Therapy)
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.4
          value
          62.1
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          4
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      0=Fully active
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      1=Restricted in physically strenuous activity
    param Type
    NUMBER
    title
    Performance Status
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Obatoclax mesylate IV 14 mg/m^2
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Obatoclax mesylate IV 30 mg/m^2
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Obatoclax mesylate IV 40 mg/m^2
    param Type
    NUMBER
    title
    Dose Level
    unit Of Measure
    participants
population Description
One patient withdrew prior to beginning treatment and was replaced, thus, will be excluded in all analysis.
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      10
    units
    Participants
groups
  1. description
    Patients receive obatoclax mesylate IV over 3 hours and bortezomib (1.3 mg/m\^2) IV on days 1, 4, 8, and 11. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
    id
    BG000
    title
    Treatment (Enzyme Inhibitor Therapy)
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          10.4
          value
          62.1
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          4
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          6
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          10
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          1
      title
      0=Fully active
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          9
      title
      1=Restricted in physically strenuous activity
    param Type
    NUMBER
    title
    Performance Status
    unit Of Measure
    participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Obatoclax mesylate IV 14 mg/m^2
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Obatoclax mesylate IV 30 mg/m^2
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Obatoclax mesylate IV 40 mg/m^2
    param Type
    NUMBER
    title
    Dose Level
    unit Of Measure
    participants
population Description
One patient withdrew prior to beginning treatment and was replaced, thus, will be excluded in all analysis.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice